US Patent Issued to MILTENYI BIOTEC on Jan. 13 for "Hematopoietic cells with a modified CD antigen for reducing side effects of cancer immunotherapy" (German Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,434, issued on Jan. 13, was assigned to MILTENYI BIOTEC GMBH (Bergisch Gladbach, Germany).

"Hematopoietic cells with a modified CD antigen for reducing side effects of cancer immunotherapy" was invented by Michael Lutteropp (Bergisch Gladbach, Germany), Anne Richter (Bergisch Gladbach, Germany), Andrew Kaiser (Bergisch Gladbach, Germany), Mario Assenmacher (Bergisch Gladbach, Germany) and Stefan Miltenyi (Bergisch Gladbach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a system that comprises pharmaceutical agents for use in immunotherapy for reducing the side-effects of an antigen-recognizing receptor against antigen...